LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice

Cardiovascular diseases arising from atherosclerosis are the leading causes of mortality and morbidity worldwide. Lipid-lowering agents have been developed in order to treat hypercholesterolemia, a major risk factor for atherosclerosis. However, the prevalence of cardiovascular diseases is increasin...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jong-Gil, Jeongs, Se-Jin, Yu, Jinha, Kim, Gyudong, Jeong, Lak Shin, Oh, Goo Taeg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235094/
https://www.ncbi.nlm.nih.gov/pubmed/29936931
http://dx.doi.org/10.5483/BMBRep.2018.51.10.098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235094/
https://www.ncbi.nlm.nih.gov/pubmed/29936931
http://dx.doi.org/10.5483/BMBRep.2018.51.10.098

Ejemplares similares